Document Type
Patent
Publication Date
October 2009
Patent Number
E040937
Abstract
A method for the early diagnosing of selected adenocarcinomas in a human comprising the steps of removing a bodily sample from the human, and assaying the bodily sample for elevated expression of a specific gene. The gene being assayed for in the bodily sample is the TGFB-4 gene (hereinafter referred to as the endometrial bleeding associated factor (ebaf) gene. The bodily sample can be tissue from a specific organ in the body, or a blood sample. Increased levels of ebaf in the sample relative to basal levels may be indicative of a mucinous adenocarcinoma of the colon or ovaries, or an adenocarcinoma of the testis.
Application Number
11/801,427
Recommended Citation
Tabibzadeh, Siamak and Kothapalli, Ravi, "Nucleic acids encoding an endometrial bleeding associated factor (EBAF)" (2009). USF Patents. 569.
https://digitalcommons.usf.edu/usf_patents/569
Assignees
University of South Florida
Filing Date
05/09/2007
Primary/U.S. Class
536/235
